logo

Otonomy Inc. (OTIC)



Trade OTIC now with
  Date
  Headline
8/30/2017 7:04:57 AM Otonomy Reports Results For Its AVERTS-1 Phase 3 Clinical Trial Of OTIVIDEX In Patients With Ménière’s Disease
8/30/2017 7:04:21 AM Otonomy Trading Halted; Expected To Resume At 7:30 AM ET
1/19/2017 7:35:08 AM Otonomy Initiates Patient Enrollment In Phase 2 Trial Of OTO-104 As Protectant Against Cisplatin-Induced Hearing Loss